当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析

人福医药

(600079)

  

流通市值:297.27亿  总市值:315.86亿
流通股本:15.36亿   总股本:16.32亿

人福医药(600079)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润22.83亿元,每股收益1.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1961923.44万元,未分配利润908455.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3670842.46万元,负债1708919.02万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入18,111,717,932.0412,382,998,383.936,225,735,090.2122,337,719,417.55
营业总成本15,716,222,804.2610,673,265,170.645,431,915,788.8519,851,774,860.03
营业利润2,743,233,135.652,006,246,262.461,011,384,677.183,516,027,779.31
利润总额2,707,276,437.031,992,448,935.51,003,206,846.113,426,052,865.15
净利润2,283,150,716.381,690,687,483.37861,113,526.513,071,302,318.38
其他综合收益88,219,201.6662,058,474.861,583,453.59155,771,021.3
综合收益总额2,371,369,918.041,752,745,958.23862,696,980.13,227,073,339.68
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计20,199,989,726.8319,764,453,634.0618,573,673,268.1319,427,909,515.04
非流动资产合计16,508,434,916.0717,151,667,584.7516,843,573,193.6816,595,112,238.05
资产总计36,708,424,642.936,916,121,218.8135,417,246,461.8136,023,021,753.09
流动负债合计14,059,468,585.9615,003,193,271.0113,677,433,536.7515,142,743,849.14
非流动负债合计3,029,721,6122,950,274,221.22,998,589,172.722,937,994,920.25
负债合计17,089,190,197.9617,953,467,492.2116,676,022,709.4718,080,738,769.39
归属于母公司股东权益合计16,740,310,436.2916,204,944,570.8815,742,386,028.2515,036,993,291.57
股东权益合计19,619,234,444.9418,962,653,726.618,741,223,752.3417,942,282,983.7
负债和股东权益合计36,708,424,642.936,916,121,218.8135,417,246,461.8136,023,021,753.09
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计17,265,475,023.611,447,358,681.035,145,179,609.3922,960,821,474.21
经营活动现金流出小计16,292,096,789.5211,062,439,613.325,663,257,165.4320,519,750,420.05
经营活动产生的现金流量净额973,378,234.08384,919,067.71-518,077,556.042,441,071,054.16
投资活动现金流入小计1,085,691,383.57306,124,018.98186,580,381.876,668,770,276.13
投资活动现金流出小计1,846,324,946.981,241,485,736.29404,212,9545,441,979,915.64
投资活动产生的现金流量净额-760,633,563.41-935,361,717.31-217,632,572.131,226,790,360.49
筹资活动现金流入小计7,765,754,967.795,802,045,367.053,065,799,493.0511,086,228,433.62
筹资活动现金流出小计8,668,188,602.626,418,851,200.523,788,735,176.0615,331,170,702.64
筹资活动产生的现金流量净额-902,433,634.83-616,805,833.47-722,935,683.01-4,244,942,269.02
汇率变动对现金及现金等价物的影响19,299,361.825,497,678.58-7,964,666.9848,451,516.43
现金及现金等价物净增加额-670,389,602.36-1,141,750,804.49-1,466,610,478.16-528,629,337.94
期末现金及现金等价物余额3,666,791,638.823,195,430,436.692,870,570,763.024,337,181,241.18
TOP↑